The National Medical Products Administration (NMPA) published the “Standards for Cosmetic Efficacy Claim Evaluation”, which will come into force from 1 January 2022. Cosmetic notifiers or registrants need to submit a summary of their product efficacy claims to an online platform specified by the NMPA.
According to the document, the summary of product efficacy claims shall include at least:
- Basic product information
- Parameters and evaluation institutions
- Brief description of evaluation methods and results
- Conclusion and relevance of test result and product claims
The standard classified different evaluation methods for different product claims, products that are not required to submit the summary, also provided a format of the summary of product efficacy claims.
Contact RegASK to get prepared for these potential regulatory changes. Get in touch with RegASK’s experts.
Contact RegASK for more details Read more
